Radiotherapy of classic Kaposi's sarcoma in Taiwan, an area where classic Kaposi's sarcoma is not prevalent

Kuo Ming Huang, Chih Hung Hsu, Jason Chia Hsien Cheng, Ming Kuen Lai, Shiu Chen Jeng, Lai Lei Ting, Wen Tao Huang

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Classic Kaposi's sarcoma (KS), a neoplastic disease of vascular endothelial cells of the skin, is relatively prevalent in Eastern Europe and the Mediterranean region and radiation is one of the standard therapies. The clinical presentation and treatment results of classic KS from other regions have rarely been reported. Patients and Methods: Between 1994 and 2006, patients who had histologically confirmed KS and no immunodeficiency status due to human immunodeficiency virus infection or organ transplantation, and were treated with radiotherapy at Department of Oncology, National Taiwan University Hospital, Japan, were reviewed. Results: A total of 17 classic KS patients, with a median age of 69 years, were studied over a period of 12 years. All classic KS lesions involved lower extremities. Radiotherapy was delivered with either a 60Co unit or a linear accelerator, with the most commonly prescribed treatment being 3 Gy per fraction to a total dose of 39 Gy. In addition, several techniques using bolus were adopted to improve the radiation distribution over the skin of lower extremities. All irradiated KS lesions responded, with a complete response rate of 76%. The overall survival and progression-free survival rates of the group at 5 years were 85% and 58%, respectively. Conclusion: Radiation therapy for classic KS patients in a non-prevalent area, such as Taiwan, is safe and effective.

Original languageEnglish
Pages (from-to)4659-4663
Number of pages5
JournalAnticancer Research
Volume26
Issue number6 C
Publication statusPublished - Nov 1 2006
Externally publishedYes

Fingerprint

Kaposi's Sarcoma
Taiwan
Radiotherapy
Lower Extremity
Radiation
Mediterranean Region
Eastern Europe
Particle Accelerators
Skin
Organ Transplantation
Virus Diseases
Disease-Free Survival
Japan
Therapeutics
Survival Rate
Endothelial Cells
HIV
Survival

Keywords

  • Aquaplast RT™
  • Bolus
  • Kaposi's sarcoma
  • Radiotherapy
  • Thermoplastic

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Huang, K. M., Hsu, C. H., Cheng, J. C. H., Lai, M. K., Jeng, S. C., Ting, L. L., & Huang, W. T. (2006). Radiotherapy of classic Kaposi's sarcoma in Taiwan, an area where classic Kaposi's sarcoma is not prevalent. Anticancer Research, 26(6 C), 4659-4663.

Radiotherapy of classic Kaposi's sarcoma in Taiwan, an area where classic Kaposi's sarcoma is not prevalent. / Huang, Kuo Ming; Hsu, Chih Hung; Cheng, Jason Chia Hsien; Lai, Ming Kuen; Jeng, Shiu Chen; Ting, Lai Lei; Huang, Wen Tao.

In: Anticancer Research, Vol. 26, No. 6 C, 01.11.2006, p. 4659-4663.

Research output: Contribution to journalArticle

Huang, KM, Hsu, CH, Cheng, JCH, Lai, MK, Jeng, SC, Ting, LL & Huang, WT 2006, 'Radiotherapy of classic Kaposi's sarcoma in Taiwan, an area where classic Kaposi's sarcoma is not prevalent', Anticancer Research, vol. 26, no. 6 C, pp. 4659-4663.
Huang, Kuo Ming ; Hsu, Chih Hung ; Cheng, Jason Chia Hsien ; Lai, Ming Kuen ; Jeng, Shiu Chen ; Ting, Lai Lei ; Huang, Wen Tao. / Radiotherapy of classic Kaposi's sarcoma in Taiwan, an area where classic Kaposi's sarcoma is not prevalent. In: Anticancer Research. 2006 ; Vol. 26, No. 6 C. pp. 4659-4663.
@article{d2639d20b407432497c6cdf85f1f32b9,
title = "Radiotherapy of classic Kaposi's sarcoma in Taiwan, an area where classic Kaposi's sarcoma is not prevalent",
abstract = "Background: Classic Kaposi's sarcoma (KS), a neoplastic disease of vascular endothelial cells of the skin, is relatively prevalent in Eastern Europe and the Mediterranean region and radiation is one of the standard therapies. The clinical presentation and treatment results of classic KS from other regions have rarely been reported. Patients and Methods: Between 1994 and 2006, patients who had histologically confirmed KS and no immunodeficiency status due to human immunodeficiency virus infection or organ transplantation, and were treated with radiotherapy at Department of Oncology, National Taiwan University Hospital, Japan, were reviewed. Results: A total of 17 classic KS patients, with a median age of 69 years, were studied over a period of 12 years. All classic KS lesions involved lower extremities. Radiotherapy was delivered with either a 60Co unit or a linear accelerator, with the most commonly prescribed treatment being 3 Gy per fraction to a total dose of 39 Gy. In addition, several techniques using bolus were adopted to improve the radiation distribution over the skin of lower extremities. All irradiated KS lesions responded, with a complete response rate of 76{\%}. The overall survival and progression-free survival rates of the group at 5 years were 85{\%} and 58{\%}, respectively. Conclusion: Radiation therapy for classic KS patients in a non-prevalent area, such as Taiwan, is safe and effective.",
keywords = "Aquaplast RT™, Bolus, Kaposi's sarcoma, Radiotherapy, Thermoplastic, Aquaplast RT™, Bolus, Kaposi's sarcoma, Radiotherapy, Thermoplastic",
author = "Huang, {Kuo Ming} and Hsu, {Chih Hung} and Cheng, {Jason Chia Hsien} and Lai, {Ming Kuen} and Jeng, {Shiu Chen} and Ting, {Lai Lei} and Huang, {Wen Tao}",
year = "2006",
month = "11",
day = "1",
language = "English",
volume = "26",
pages = "4659--4663",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6 C",

}

TY - JOUR

T1 - Radiotherapy of classic Kaposi's sarcoma in Taiwan, an area where classic Kaposi's sarcoma is not prevalent

AU - Huang, Kuo Ming

AU - Hsu, Chih Hung

AU - Cheng, Jason Chia Hsien

AU - Lai, Ming Kuen

AU - Jeng, Shiu Chen

AU - Ting, Lai Lei

AU - Huang, Wen Tao

PY - 2006/11/1

Y1 - 2006/11/1

N2 - Background: Classic Kaposi's sarcoma (KS), a neoplastic disease of vascular endothelial cells of the skin, is relatively prevalent in Eastern Europe and the Mediterranean region and radiation is one of the standard therapies. The clinical presentation and treatment results of classic KS from other regions have rarely been reported. Patients and Methods: Between 1994 and 2006, patients who had histologically confirmed KS and no immunodeficiency status due to human immunodeficiency virus infection or organ transplantation, and were treated with radiotherapy at Department of Oncology, National Taiwan University Hospital, Japan, were reviewed. Results: A total of 17 classic KS patients, with a median age of 69 years, were studied over a period of 12 years. All classic KS lesions involved lower extremities. Radiotherapy was delivered with either a 60Co unit or a linear accelerator, with the most commonly prescribed treatment being 3 Gy per fraction to a total dose of 39 Gy. In addition, several techniques using bolus were adopted to improve the radiation distribution over the skin of lower extremities. All irradiated KS lesions responded, with a complete response rate of 76%. The overall survival and progression-free survival rates of the group at 5 years were 85% and 58%, respectively. Conclusion: Radiation therapy for classic KS patients in a non-prevalent area, such as Taiwan, is safe and effective.

AB - Background: Classic Kaposi's sarcoma (KS), a neoplastic disease of vascular endothelial cells of the skin, is relatively prevalent in Eastern Europe and the Mediterranean region and radiation is one of the standard therapies. The clinical presentation and treatment results of classic KS from other regions have rarely been reported. Patients and Methods: Between 1994 and 2006, patients who had histologically confirmed KS and no immunodeficiency status due to human immunodeficiency virus infection or organ transplantation, and were treated with radiotherapy at Department of Oncology, National Taiwan University Hospital, Japan, were reviewed. Results: A total of 17 classic KS patients, with a median age of 69 years, were studied over a period of 12 years. All classic KS lesions involved lower extremities. Radiotherapy was delivered with either a 60Co unit or a linear accelerator, with the most commonly prescribed treatment being 3 Gy per fraction to a total dose of 39 Gy. In addition, several techniques using bolus were adopted to improve the radiation distribution over the skin of lower extremities. All irradiated KS lesions responded, with a complete response rate of 76%. The overall survival and progression-free survival rates of the group at 5 years were 85% and 58%, respectively. Conclusion: Radiation therapy for classic KS patients in a non-prevalent area, such as Taiwan, is safe and effective.

KW - Aquaplast RT™

KW - Bolus

KW - Kaposi's sarcoma

KW - Radiotherapy

KW - Thermoplastic

KW - Aquaplast RT™

KW - Bolus

KW - Kaposi's sarcoma

KW - Radiotherapy

KW - Thermoplastic

UR - http://www.scopus.com/inward/record.url?scp=33845917107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845917107&partnerID=8YFLogxK

M3 - Article

VL - 26

SP - 4659

EP - 4663

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6 C

ER -